Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Drug Testing

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

CDT helps employers ensure reliable, accurate and confidential drug testing tailored to meet your needs. Our services include administrative support, collections, random pool selection, analysis, medical review and reporting of results, utilizing flexible web-based solutions.
Drug Policy Development

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

A strong drug testing policy is the foundation of an effective program. Detailed policy consulting and development are our strengths. As a pioneer in the field, our experts are knowledgeable on state and federal laws that govern the employment screening process.
Training & Education Programs

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

The power of bringing in an expert to talk with employees, supervisors or other key groups cannot be underestimated. In addition, CDT provides interactive on line training and education programs. Our online reasonable suspicion supervisor training meets the DOT requirements.
Recent News & Policy Developments

FMCSA Officials to Present Details of New Drug/Alc Clearinghouse at AAMRO in Las Vegas on Dec. 9-11 11-10-2016

On Monday October 31 the Federal Motor Carrier Safety Administration (FMCSA) drug and alcohol clearinghouse final rule cleared the White House Office of Management and Budget. The final rule is expected to be published within a week or so in the federal register.

As covered in the rulemaking process, the new “clearinghouse” is essentially a central database for DOT-verified positive controlled substances and alcohol test results for CDL holders and refusals. Medical Review Officers would be required to report positive test results and refusals into the clearinghouse.

Prospective employers, acting on an application for a CDL driver position with the applicant’s written consent, would check the clearinghouse before allowing the applicant to be hired and to drive a commercial motor vehicle.

Proponents of the rulemaking say it would increase highway safety by ensuring that CDL holders, who have tested positive or have refused to submit to testing, have completed the return-to-duty process before driving a truck. It is also intended to ensure that employers are meeting their drug and alcohol testing responsibilities.

FMCSA originally proposed the rule in February 2014, and OMB received the final rule in May of this year.

At the AAMRO Annual Symposium and Comprehensive Medical Review Officer Training, December 9-11, 2016, FMSCA officials will discuss and explain details of the final rule of the new drug and alcohol clearinghouse.

FMCSA Lowers Testing Rate for 2016 12-21-2015
The Federal Motor Carrier Safety Administration (FMCSA) today announced that it will lower the random testing rate for controlled substances from the current 50 percent to 25 percent for the upcoming calendar year, effective January 1, 2016.

SAMHSA/HHS will publish the following Notices in the 15 May 2015 Federal Register 05-15-2015

SAMHSA/HHS will publish the following Notices in the 15 May 2015 Federal Register. The Notices are available in pdf format today.

         Mandatory Guidelines for Federal Workplace Drug Testing Programs using Oral Fluid that allow federal agencies to collect and test oral fluid specimens in their workplace drug testing programs.

         Mandatory Guidelines for Federal Workplace Drug Testing Programs using Urine (URMG) that revise standards and technical requirements of the current Guidelines.

Comments on the OFMG and URMG must be submitted within 60 days after publication. Instructions for submitting comments are included in the Notices.


         Oral Fluid Mandatory Guidelines. The proposed OFMG establish standards and technical requirements for oral fluid collection devices, initial oral fluid drug test analytes and methods, confirmatory oral fluid drug test analytes and methods, processes for review by a Medical Review Officer (MRO), and requirements for federal agency actions.

         Urine Mandatory Guidelines. The proposed revisions to the Mandatory Guidelines for Federal Workplace Drug Testing Programs will revise the initial and confirmatory drug test analytes and methods for urine testing, revise the cutoff for reporting a specimen as adulterated based on low pH, revise the requalification requirements for individuals serving as MROs and, where appropriate, include references to the use of an alternate specimen in federal workplace drug testing programs.

         Testing for new drugs: In addition to expanding testing for both oral fluid and urine, the URMG and OFMG will include urine and oral testing procedures for four Schedule II prescription medications: hydrocodone, hydromorphone, oxycodone, and oxymorphone not currently included in the Mandatory Guidelines.

Mixed Results for Marijuana Initiatives at the Polls 11-05-2014
The Nov. 4 election showed relatively small amounts of support for pro-marijuana initiatives. Even though more states approved these initiatives, they were done by small margin.
Here are some highlights:

Medical Marijuana
Approved in Guam (Proposal 14A by 56% to 44%)
Rejected in Florida (Amendment 2: 43% to 57%)

Legal Personal Use
Approved in Washington D.C. (Initiative 71- 64% in favor - possession)
Approved in Oregon (Measure 91 - 54% approval - retail shops)
Approved in Alaska (Ballot measure 2 - leading 52% with 97% of votes in - retail shops)
Approved in South Portland, ME (52% to 48%)
Rejected in Lewiston, ME (55% to 45%)

For more information on the recent election results regarding marijuana, please visit Smart Approaches to Marijuana (SAM).

Feds Launch Massive Crackdown on Synthetic Drug Dealers 05-07-2014
WASHINGTON — The Drug Enforcement Administration on Wednesday broadened its national crackdown on synthetic drug manufacturers, wholesalers and retailers as federal agents served hundreds of search and arrest warrants in at least 25 states.
Click here to review the full article.

California Initiative Will Enact Nation's First Law Requiring Random Drug Testing Of Physicians 04-16-2014
A USA Today report finds that 103,000 medical professionals are abusing prescription drugs every year, yet most of the addicted doctors are never caught and place their patients at risk. California will be the first state in the nation to require random drug testing of doctors if voters approve an initiative measure that is headed to the November ballot.
Click here to review the full article.

FMCSA Proposes National Drug and Alcohol Testing Clearinghouse for Commercial Truck and Bus Drivers 02-12-2014
WASHINGTON - The U.S. Department of Transportation's Federal Motor Carrier Safety Administration (FMCSA) today announced a proposed rule to establish a drug and alcohol clearinghouse for all national commercial driver's license (CDL) holders. The clearinghouse would help improve roadway safety by making it easier to determine whether a truck or bus driver is prohibited from operating a commercial motor vehicle for failing to comply with federal drug and alcohol regulations, including mandatory testing.

Emerging Regulations – Prescription Drugs and Oral Fluid 02-08-2012
Last month, the Substance Abuse and Mental Health Services Administration (SAMHSA) announced that it accepted the recommendations of its Drug Testing Advisory Board (DTAB), and will proceed with drafting revisions to the DHHS Mandatory Guidelines for Federal Workplace Drug Testing Programs. The changes would include:
  1. Expanding the drug testing panel to include additional Schedule II prescription medications (e.g., oxycodone, oxymorphone, hydrocodone and hydromorphone).
  2. Including oral fluid as an alternative specimen for Federal Drug Free Workplace testing.
Click here to review the full article.

Hydrocodone and Oxycodones Lead U.S. General Workforce Positives 10-11-2011
American workers continue to use prescription opiates at relatively high levels, according to Drug Testing Index™ (DTI) data released today by Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services. Hydrocodone and oxycodones remain the most detected prescription opiates in the U.S. general workforce, with 1.3% and 1.1% positivity rates, respectively, in the first half of 2011. Compared to 2005 levels, oxycodones are 96% higher (0.56% vs. 1.1%) and hydrocodone 47% higher (0.88% vs. 1.3%) in positive prevalence.

DOT Extends The Use Of Old Chain of Custody Forms Until November 30th, 2011 09-27-2011
Among amendments to the Interim ruling; employers that fall under the DOT drug testing regulations, 49 CFR Part 40, can continue to use old CCF forms until November 30, 2011. This extension will provide the DOT and employers more time to implement the use of the new forms. We have done an illustration in order to identify the new COC forms here.

Quest Diagnostics Issued Its Annual Drug Testing Index Report 09-12-2011
The study includes its first state-by-state analysis of methamphetamine positives, based on more than 4.5 million urine specimens collected from the general U.S. workforce from January-December 2010, revealing that several Western and Midwestern states register dramatically higher workforce positive prevalence rates for methamphetamine than the national average. The report also shows that while efforts around the country to control availability of the highly addictive substance and educate against its use may be making progress in some areas, the drug's attraction among U.S. workers may be moving eastward.

DEA Moves to Emergency Control Synthetic Stimulants (Bath Salts) 09-07-2011
The United States Drug Enforcement Administration (DEA) is using its emergency scheduling authority to temporarily control three synthetic stimulants (Mephedrone , 3,4 methylenedioxypyrovalerone (MDPV) and Methylone). This action was necessary to protect the public from the imminent hazard posed by these dangerous chemicals. Except as authorized by law, this action will make possessing and selling these chemicals or the products that contain them illegal in the U.S. for at least one year while the DEA and the United States Department of Health and Human Services (DHHS) further study whether these chemicals should be permanently controlled.

"Bath Salt" Abuse is a Growing Menace 01-31-2011
The MEDTOX Drug Abuse Recognition (DAR) Hotline has been peppered with calls about ingestion and abuse of bath salts over the last several months. The first Hotline calls were fielded in June of 2010; volume hit a peak this month. Abuse of bath salts and particular strains of powdered plant food has now been reported by a number of media outlets, as well as by state and federal law enforcement agencies. This activity is real and it represents a notable public safety threat. Readers should be sensitive to this substance abuse and be prepared for bad outcomes for some users. Our staff believes the problem warrants a special "be on the lookout" advisory for our readers.